Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/35287
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBadrick T.en
dc.contributor.authorKumar B.en
dc.contributor.authorHaffajee Z.A.M.en
dc.contributor.authorFrancis G.en
dc.contributor.authorPeck M.en
dc.date.accessioned2021-05-14T11:54:47Zen
dc.date.available2021-05-14T11:54:47Zen
dc.date.copyright2019en
dc.date.created20190530en
dc.date.issued2019-05-30en
dc.identifier.citationApplied Immunohistochemistry and Molecular Morphology. 27 (5) (pp 339-344), 2019. Date of Publication: 01 May 2019.en
dc.identifier.issn1541-2016en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/35287en
dc.description.abstractThe Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP) Anatomical Pathology provides a comprehensive External Quality Assurance (EQA) exercise to review the reporting of immunohistochemistry (IHC) and in-situ hybridization (ISH) breast markers through an audit of clinical results. The aim of this exercise was to provide information regarding the quality of breast marker testing within clinical laboratories from 2005 to 2015. This comprehensive audit included estrogen, progesterone, and HER2 marker reporting. This was an important quality assurance activity established in response to ongoing difficulties experienced in laboratories in this area of testing.© Copyright 2019 Wolters Kluwer Health, Inc. All rights reserved.en
dc.languageEnglishen
dc.languageenen
dc.publisherLippincott Williams and Wilkinsen
dc.relation.ispartofApplied Immunohistochemistry and Molecular Morphologyen
dc.titleThe Royal College of Pathologists of Australasia Quality Assurance Program: Immunohistochemistry Breast Marker Audit Overview 2005-2015.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1097/PAI.0000000000000621en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid29189257 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29189257]en
dc.identifier.source627799906en
dc.identifier.institution(Haffajee, Peck, Badrick) Department of Anatomical Pathology, Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP), 8 Herbert Street, St Leonards, Sydney, NSW 2065, Australia (Kumar) Department of Histopathology, Monash Health, Monash Medical Centre, Melbourne, VIC, Australia (Francis) Department of Histopathology, Genomics for Life, QLD, Australiaen
dc.description.addressZ.A.M. Haffajee, Department of Anatomical Pathology, Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP), 8 Herbert Street, St Leonards, Sydney, NSW 2065, Australia. E-mail: Zenobia.haffajee@rcpaqap.com.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.subect.keywordsASCO CAP CEP17 EQA ER HER2 IHC ISH PR RCPAQAPen
dc.identifier.authoremailHaffajee Z.A.M.; Zenobia.haffajee@rcpaqap.com.auen
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptPathology-
Appears in Collections:Articles
Show simple item record

Page view(s)

22
checked on Feb 11, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.